{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T21:02:18Z","timestamp":1787950938907,"version":"build-2784847793"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Natural Science Foundation of Guangxi Province of China","award":["2023GXNSFAA026022"],"award-info":[{"award-number":["2023GXNSFAA026022"]}]},{"name":"The Health Commission of Guangxi Zhuang Autonomous Region Natural Science Project","award":["Z20211324"],"award-info":[{"award-number":["Z20211324"]}]},{"name":"The Health Commission of Guangxi Zhuang Autonomous Region Self-funded Project","award":["Z2014474"],"award-info":[{"award-number":["Z2014474"]}]},{"name":"The Health Commission of Guangxi Zhuang Autonomous Region Self-funded Project","award":["Z20210657"],"award-info":[{"award-number":["Z20210657"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hepatocellular carcinoma (HCC) is a solid tumor prone to chemotherapy resistance, and combined immunotherapy is expected to bring a breakthrough in HCC treatment. However, the tumor and tumor microenvironment (TME) of HCC is highly complex and heterogeneous, and there are still many unknowns regarding tumor cell stemness and metabolic reprogramming in HCC. In this study, we combined single-cell RNA sequencing data from 27 HCC tumor tissues and 4 adjacent non-tumor tissues, and bulk RNA sequencing data from 374 of the Cancer Genome Atlas (TCGA)-liver hepatocellular carcinoma (LIHC) samples to construct a global single-cell landscape atlas of HCC. We analyzed the enrichment of signaling pathways of different cells in HCC, and identified the developmental trajectories of cell subpopulations in the TME using pseudotime analysis. Subsequently, we performed transcription factors regulating different subpopulations and gene regulatory network analysis, respectively. In addition, we estimated the stemness index of tumor cells and analyzed the intercellular communication between tumors and key TME cell clusters. We identified novel HCC cell clusters that specifically express HP (HCC_HP), which may lead to higher tumor differentiation and tumor heterogeneity. In addition, we found that the HP gene expression-positive neutrophil cluster (Neu_AIF1) had extensive and strong intercellular communication with HCC cells, tumor endothelial cells (TEC) and cancer-associated fibroblasts (CAF), suggesting that clearance of this new cluster may inhibit HCC progression. Furthermore, ErbB signaling pathway and GnRH signaling pathway were found to be upregulated in almost all HCC tumor-associated stromal cells and immune cells, except NKT cells. Moreover, the high intercellular communication between HCC and HSPA1-positive TME cells suggests that the immune microenvironment may be reprogrammed. In summary, our present study depicted the single-cell landscape heterogeneity of human HCC, identified new cell clusters in tumor cells and neutrophils with potential implications for immunotherapy research, discovered complex intercellular communication between tumor cells and TME cells.<\/jats:p>","DOI":"10.1038\/s41598-023-46132-w","type":"journal-article","created":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T07:03:30Z","timestamp":1698822210000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Single-cell RNA sequencing revealed potential targets for immunotherapy studies in hepatocellular carcinoma"],"prefix":"10.1038","volume":"13","author":[{"given":"Zhouhua","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinping","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingdong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianzhen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cailing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunda","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shixiong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiamin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,1]]},"reference":[{"issue":"3","key":"46132_CR1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41571-021-00573-2","volume":"19","author":"JM Llovet","year":"2022","unstructured":"Llovet, J. M. et al. Immunotherapies for hepatocellular carcinoma. Nat. Rev. Clin. Oncol. 19(3), 151\u2013172 (2022).","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"46132_CR2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41421-023-00529-z","volume":"9","author":"GQ Zhu","year":"2023","unstructured":"Zhu, G. Q. et al. CD36(+) cancer-associated fibroblasts provide immunosuppressive microenvironment for hepatocellular carcinoma via secretion of macrophage migration inhibitory factor. Cell Discov. 9(1), 25 (2023).","journal-title":"Cell Discov."},{"issue":"8","key":"46132_CR3","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/s41575-021-00438-0","volume":"18","author":"B Sangro","year":"2021","unstructured":"Sangro, B., Sarobe, P., Hervas-Stubbs, S. & Melero, I. Advances in immunotherapy for hepatocellular carcinoma. Nat. Rev. Gastroenterol. Hepatol. 18(8), 525\u2013543 (2021).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"8","key":"46132_CR4","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1158\/2326-6066.CIR-20-1026","volume":"9","author":"F Hong","year":"2021","unstructured":"Hong, F. et al. Single-cell analysis of the pan-cancer immune microenvironment and scTIME portal. Cancer Immunol. Res. 9(8), 939\u2013951 (2021).","journal-title":"Cancer Immunol. Res."},{"issue":"51","key":"46132_CR5","doi-asserted-by":"publisher","first-page":"eabg3750","DOI":"10.1126\/sciadv.abg3750","volume":"7","author":"R Wu","year":"2021","unstructured":"Wu, R. et al. Comprehensive analysis of spatial architecture in primary liver cancer. Sci. Adv. 7(51), eabg3750 (2021).","journal-title":"Sci. Adv."},{"issue":"17","key":"46132_CR6","doi-asserted-by":"publisher","first-page":"8322","DOI":"10.7150\/thno.62378","volume":"11","author":"Z Li","year":"2021","unstructured":"Li, Z., Sun, C. & Qin, Z. Metabolic reprogramming of cancer-associated fibroblasts and its effect on cancer cell reprogramming. Theranostics 11(17), 8322\u20138336 (2021).","journal-title":"Theranostics"},{"issue":"1","key":"46132_CR7","doi-asserted-by":"publisher","first-page":"101985","DOI":"10.1016\/j.isci.2020.101985","volume":"24","author":"SE Shelton","year":"2021","unstructured":"Shelton, S. E., Nguyen, H. T., Barbie, D. A. & Kamm, R. D. Engineering approaches for studying immune-tumor cell interactions and immunotherapy. iScience 24(1), 101985 (2021).","journal-title":"iScience"},{"issue":"1","key":"46132_CR8","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12929-022-00866-3","volume":"29","author":"A Tiwari","year":"2022","unstructured":"Tiwari, A., Trivedi, R. & Lin, S. Y. Tumor microenvironment: Barrier or opportunity towards effective cancer therapy. J. Biomed. Sci. 29(1), 83 (2022).","journal-title":"J. Biomed. Sci."},{"issue":"2","key":"46132_CR9","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.cell.2018.03.034","volume":"173","author":"TM Malta","year":"2018","unstructured":"Malta, T. M. et al. Machine learning identifies stemness features associated with oncogenic dedifferentiation. Cell 173(2), 338\u201354 e15 (2018).","journal-title":"Cell"},{"issue":"4","key":"46132_CR10","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41575-021-00568-5","volume":"19","author":"D Geh","year":"2022","unstructured":"Geh, D. et al. Neutrophils as potential therapeutic targets in hepatocellular carcinoma. Nat. Rev. Gastroenterol. Hepatol. 19(4), 257\u2013273 (2022).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"7938","key":"46132_CR11","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41586-022-05400-x","volume":"612","author":"R Xue","year":"2022","unstructured":"Xue, R. et al. Liver tumour immune microenvironment subtypes and neutrophil heterogeneity. Nature 612(7938), 141\u2013147 (2022).","journal-title":"Nature"},{"issue":"7","key":"46132_CR12","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.7150\/thno.42385","volume":"10","author":"X Dai","year":"2020","unstructured":"Dai, X. et al. Targeting CAMKII to reprogram tumor-associated macrophages and inhibit tumor cells for cancer immunotherapy with an injectable hybrid peptide hydrogel. Theranostics 10(7), 3049\u20133063 (2020).","journal-title":"Theranostics"},{"issue":"4","key":"46132_CR13","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.ccell.2019.08.007","volume":"36","author":"L Ma","year":"2019","unstructured":"Ma, L. et al. Tumor cell biodiversity drives microenvironmental reprogramming in liver cancer. Cancer Cell 36(4), 418-430 e6 (2019).","journal-title":"Cancer Cell"},{"issue":"5","key":"46132_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/mmr.2022.12855","volume":"26","author":"F Wen","year":"2022","unstructured":"Wen, F., Tang, X., Xu, L. & Qu, H. Comparison of single-nucleus and single-cell transcriptomes in hepatocellular carcinoma tissue. Mol. Med. Rep. 26(5), 1\u201312 (2022).","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"46132_CR15","doi-asserted-by":"publisher","first-page":"7533","DOI":"10.1038\/s41467-022-35291-5","volume":"13","author":"L Ma","year":"2022","unstructured":"Ma, L. et al. Multiregional single-cell dissection of tumor and immune cells reveals stable lock-and-key features in liver cancer. Nat. Commun. 13(1), 7533 (2022).","journal-title":"Nat. Commun."},{"issue":"3","key":"46132_CR16","doi-asserted-by":"publisher","first-page":"100278","DOI":"10.1016\/j.jhepr.2021.100278","volume":"3","author":"VL Payen","year":"2021","unstructured":"Payen, V. L. et al. Single-cell RNA sequencing of human liver reveals hepatic stellate cell heterogeneity. JHEP Rep. 3(3), 100278 (2021).","journal-title":"JHEP Rep."},{"issue":"20","key":"46132_CR17","first-page":"e120","volume":"46","author":"M Karimzadeh","year":"2018","unstructured":"Karimzadeh, M., Ernst, C., Kundaje, A. & Hoffman, M. M. Umap and Bismap: Quantifying genome and methylome mappability. Nucleic Acids Res. 46(20), e120 (2018).","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"46132_CR18","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s13059-021-02356-5","volume":"22","author":"VH Do","year":"2021","unstructured":"Do, V. H. & Canzar, S. A generalization of t-SNE and UMAP to single-cell multimodal omics. Genome Biol. 22(1), 130 (2021).","journal-title":"Genome Biol."},{"key":"46132_CR19","doi-asserted-by":"publisher","first-page":"939948","DOI":"10.3389\/fonc.2022.939948","volume":"12","author":"JH Li","year":"2022","unstructured":"Li, J. H. et al. Integrated multi-omics analysis identifies ENY2 as a predictor of recurrence and a regulator of telomere maintenance in hepatocellular carcinoma. Front. Oncol. 12, 939948 (2022).","journal-title":"Front. Oncol."},{"issue":"1","key":"46132_CR20","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1186\/s12935-021-02154-w","volume":"21","author":"C Wen-Jin","year":"2021","unstructured":"Wen-Jin, C. et al. Study of cellular heterogeneity and differential dynamics of autophagy in human embryonic kidney development by single-cell RNA sequencing. Cancer Cell Int. 21(1), 460 (2021).","journal-title":"Cancer Cell Int."},{"key":"46132_CR21","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/1476-4598-13-196","volume":"13","author":"KT Ng","year":"2014","unstructured":"Ng, K. T. et al. Clinical relevance and therapeutic potential of angiopoietin-like protein 4 in hepatocellular carcinoma. Mol. Cancer 13, 196 (2014).","journal-title":"Mol. Cancer"},{"issue":"2","key":"46132_CR22","doi-asserted-by":"publisher","first-page":"484","DOI":"10.7150\/thno.38060","volume":"10","author":"F Lu","year":"2020","unstructured":"Lu, F. et al. A tumor suppressor enhancing module orchestrated by GATA4 denotes a therapeutic opportunity for GATA4 deficient HCC patients. Theranostics 10(2), 484\u2013497 (2020).","journal-title":"Theranostics"},{"key":"46132_CR23","doi-asserted-by":"publisher","first-page":"869967","DOI":"10.3389\/fgene.2022.869967","volume":"13","author":"F Li","year":"2022","unstructured":"Li, F. et al. Relationship between CNVs and immune cells infiltration in gastric tumor microenvironment. Front. Genet. 13, 869967 (2022).","journal-title":"Front. Genet."},{"issue":"1","key":"46132_CR24","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28(1), 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"46132_CR25","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28(11), 1947\u20131951 (2019).","journal-title":"Protein Sci."},{"issue":"D1","key":"46132_CR26","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/nar\/gkac963","volume":"51","author":"M Kanehisa","year":"2023","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Kawashima, M. & Ishiguro-Watanabe, M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 51(D1), D587\u2013D592 (2023).","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"46132_CR27","first-page":"100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu, T. et al. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innovation (Camb) 2(3), 100141 (2021).","journal-title":"Innovation (Camb)"},{"issue":"3","key":"46132_CR28","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.molcel.2018.07.017","volume":"71","author":"SD Pope","year":"2018","unstructured":"Pope, S. D. & Medzhitov, R. Emerging principles of gene expression programs and their regulation. Mol. Cell 71(3), 389\u2013397 (2018).","journal-title":"Mol. Cell"},{"issue":"7","key":"46132_CR29","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1038\/s41596-020-0336-2","volume":"15","author":"B Van de Sande","year":"2020","unstructured":"Van de Sande, B. et al. A scalable SCENIC workflow for single-cell gene regulatory network analysis. Nat. Protoc. 15(7), 2247\u20132276 (2020).","journal-title":"Nat. Protoc."},{"issue":"11","key":"46132_CR30","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/nmeth.4463","volume":"14","author":"S Aibar","year":"2017","unstructured":"Aibar, S. et al. SCENIC: Single-cell regulatory network inference and clustering. Nat. Methods 14(11), 1083\u20131086 (2017).","journal-title":"Nat. Methods"},{"issue":"D1","key":"46132_CR31","doi-asserted-by":"publisher","first-page":"D165","DOI":"10.1093\/nar\/gkab1113","volume":"50","author":"JA Castro-Mondragon","year":"2022","unstructured":"Castro-Mondragon, J. A. et al. JASPAR 2022: The 9th release of the open-access database of transcription factor binding profiles. Nucleic Acids Res. 50(D1), D165\u2013D173 (2022).","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"46132_CR32","doi-asserted-by":"publisher","first-page":"108597","DOI":"10.1016\/j.celrep.2020.108597","volume":"34","author":"P Chen","year":"2021","unstructured":"Chen, P., Hsu, W. H., Han, J., Xia, Y. & DePinho, R. A. Cancer stemness meets immunity: From mechanism to therapy. Cell Rep. 34(1), 108597 (2021).","journal-title":"Cell Rep."},{"issue":"3","key":"46132_CR33","doi-asserted-by":"publisher","first-page":"e1006701","DOI":"10.1371\/journal.pcbi.1006701","volume":"15","author":"M Mounir","year":"2019","unstructured":"Mounir, M. et al. New functionalities in the TCGAbiolinks package for the study and integration of cancer data from GDC and GTEx. PLoS Comput. Biol. 15(3), e1006701 (2019).","journal-title":"PLoS Comput. Biol."},{"issue":"8","key":"46132_CR34","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1093\/nar\/gkv1507","volume":"44","author":"A Colaprico","year":"2016","unstructured":"Colaprico, A. et al. TCGAbiolinks: An R\/Bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res. 44(8), e71 (2016).","journal-title":"Nucleic Acids Res."},{"issue":"8","key":"46132_CR35","doi-asserted-by":"publisher","first-page":"100293","DOI":"10.1016\/j.patter.2021.100293","volume":"2","author":"O Lapuente-Santana","year":"2021","unstructured":"Lapuente-Santana, O., van Genderen, M., Hilbers, P. A. J., Finotello, F. & Eduati, F. Interpretable systems biomarkers predict response to immune-checkpoint inhibitors. Patterns (N Y) 2(8), 100293 (2021).","journal-title":"Patterns (N Y)"},{"issue":"4","key":"46132_CR36","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1002\/ajh.23623","volume":"89","author":"AW Shih","year":"2014","unstructured":"Shih, A. W., McFarlane, A. & Verhovsek, M. Haptoglobin testing in hemolysis: Measurement and interpretation. Am. J. Hematol. 89(4), 443\u2013447 (2014).","journal-title":"Am. J. Hematol."},{"issue":"14","key":"46132_CR37","doi-asserted-by":"publisher","first-page":"5369","DOI":"10.7150\/ijbs.73949","volume":"18","author":"H Cao","year":"2022","unstructured":"Cao, H. et al. Tumor microenvironment and its implications for antitumor immunity in cholangiocarcinoma: Future perspectives for novel therapies. Int. J. Biol. Sci. 18(14), 5369\u20135390 (2022).","journal-title":"Int. J. Biol. Sci."},{"key":"46132_CR38","doi-asserted-by":"publisher","first-page":"756722","DOI":"10.3389\/fimmu.2021.756722","volume":"12","author":"Q Yang","year":"2021","unstructured":"Yang, Q. et al. Single-cell RNA sequencing reveals the heterogeneity of tumor-associated macrophage in non-small cell lung cancer and differences between sexes. Front. Immunol. 12, 756722 (2021).","journal-title":"Front. Immunol."},{"issue":"3","key":"46132_CR39","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1053\/j.gastro.2017.06.007","volume":"153","author":"D Sia","year":"2017","unstructured":"Sia, D. et al. Identification of an immune-specific class of hepatocellular carcinoma, based molecular features. Gastroenterology. 153(3), 812\u2013826 (2017).","journal-title":"Gastroenterology."},{"issue":"6","key":"46132_CR40","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.3390\/cells9061331","volume":"9","author":"YC Liu","year":"2020","unstructured":"Liu, Y. C., Yeh, C. T. & Lin, K. H. Cancer stem cell functions in hepatocellular carcinoma and comprehensive therapeutic strategies. Cells 9(6), 1331 (2020).","journal-title":"Cells"},{"key":"46132_CR41","doi-asserted-by":"publisher","first-page":"105144","DOI":"10.1016\/j.phrs.2020.105144","volume":"161","author":"L Yi","year":"2020","unstructured":"Yi, L. et al. Integrative stemness characteristics associated with prognosis and the immune microenvironment in esophageal cancer. Pharmacol. Res. 161, 105144 (2020).","journal-title":"Pharmacol. Res."},{"issue":"3","key":"46132_CR42","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1002\/hep.24739","volume":"55","author":"KH Tang","year":"2012","unstructured":"Tang, K. H. et al. CD133(+) liver tumor-initiating cells promote tumor angiogenesis, growth, and self-renewal through neurotensin\/interleukin-8\/CXCL1 signaling. Hepatology 55(3), 807\u2013820 (2012).","journal-title":"Hepatology"},{"key":"46132_CR43","doi-asserted-by":"publisher","first-page":"574180","DOI":"10.1155\/2012\/574180","volume":"2012","author":"O Kimura","year":"2012","unstructured":"Kimura, O., Kondo, Y. & Shimosegawa, T. PPAR could contribute to the pathogenesis of hepatocellular carcinoma. PPAR Res. 2012, 574180 (2012).","journal-title":"PPAR Res."},{"issue":"4","key":"46132_CR44","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.ccr.2009.09.012","volume":"16","author":"A Villanueva","year":"2009","unstructured":"Villanueva, A., Savic, R. & Llovet, J. M. Lymphotoxins: New targets for hepatocellular carcinoma. Cancer Cell 16(4), 272\u2013273 (2009).","journal-title":"Cancer Cell"},{"issue":"5979","key":"46132_CR45","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1126\/science.1185837","volume":"328","author":"JD Shields","year":"2010","unstructured":"Shields, J. D., Kourtis, I. C., Tomei, A. A., Roberts, J. M. & Swartz, M. A. Induction of lymphoidlike stroma and immune escape by tumors that express the chemokine CCL21. Science 328(5979), 749\u2013752 (2010).","journal-title":"Science"},{"issue":"1","key":"46132_CR46","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1158\/0008-5472.CAN-08-1875","volume":"69","author":"A Issa","year":"2009","unstructured":"Issa, A., Le, T. X., Shoushtari, A. N., Shields, J. D. & Swartz, M. A. Vascular endothelial growth factor-C and C-C chemokine receptor 7 in tumor cell-lymphatic cross-talk promote invasive phenotype. Cancer Res. 69(1), 349\u2013357 (2009).","journal-title":"Cancer Res."},{"issue":"3","key":"46132_CR47","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.trecan.2016.02.002","volume":"2","author":"Q Xu","year":"2016","unstructured":"Xu, Q., Chiao, P. & Sun, Y. Amphiregulin in cancer: New insights for translational medicine. Trends Cancer 2(3), 111\u2013113 (2016).","journal-title":"Trends Cancer"},{"key":"46132_CR48","doi-asserted-by":"publisher","first-page":"15016","DOI":"10.1038\/ncomms15016","volume":"8","author":"H Zhang","year":"2017","unstructured":"Zhang, H. et al. Exosome-delivered EGFR regulates liver microenvironment to promote gastric cancer liver metastasis. Nat. Commun. 8, 15016 (2017).","journal-title":"Nat. Commun."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46132-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46132-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46132-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T16:02:04Z","timestamp":1698854524000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46132-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,1]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["46132"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-46132-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,1]]},"assertion":[{"value":"28 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18799"}}